The stability and degradation pathway of recombinant human parathyroid hormone: Deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues

被引:26
作者
Nabuchi, Y [1 ]
Fujiwara, E [1 ]
Kuboniwa, H [1 ]
Asoh, Y [1 ]
Ushio, H [1 ]
机构
[1] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Shizuoka 412, Japan
关键词
human parathyroid hormone; deamidation; cleavage; asparaginyl; aspartyl;
D O I
10.1023/A:1012115426306
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The stability of recombinant human parathyroid hormone (rhPTH) was examined under acidic to alkaline conditions; its degradation pathways were elucidated from resultant products. Methods. Degradation assay was performed in the pH range 2 to 10 at 40, 50 and 60 degrees C. The approximate molecular mass and pi values of the degradation products were estimated by electrophoresis. FAB-MS peptide mapping and amino acid composition analysis were used to determine these structures. The amount of each respective product was determined by HPLC. Results. At pH2, eight degradation products were found: 1-30rhPTH, 1-74rhPTH, 1-71rhPTH, 1-56rhPTH, 1-45rhPTH, 46-84rhPTH, 31-84rhPTH and Asp76-rhPTH; these were mainly as a consequence of peptide bond cleavage of the amide bond of Asp. At pH9, five products were found: isoAsp16-rhPTH, Asp16-rhPTH, Asp57-rhPTH, Asp76-rhPTH, 17-84rhPTH; the main degradation pathway was deamidation of Asn via a cyclic imide intermediate. Degradation products resulting from cleavage at Asp were increased in proportion to the extent that pH was lowered below 5. As pH was increased above 5, so were products resulting from deamidation of Asn. Correspondingly, levels of intact rhPTH were at a peak at pH5. Conclusions. Degradation of rhPTH under acidic conditions predominantly occurs by cleavage at Asp, whereas, above pH5, deamidation of Asn is the more prominent. rhPTH is most stable at pH5.
引用
收藏
页码:1685 / 1690
页数:6
相关论文
共 22 条
  • [1] CROSS RT, 1991, J BIOL CHEM, V266, P22549
  • [2] FRELINGER AL, 1984, J BIOL CHEM, V259, P5507
  • [3] GARDELLA TJ, 1990, J BIOL CHEM, V265, P15854
  • [4] GEIGER T, 1987, J BIOL CHEM, V262, P785
  • [5] Structure of recombinant human parathyroid hormone in solution using multidimensional NMR spectroscopy
    Gronwald, W
    Schomburg, D
    Harder, MPF
    Mayer, H
    Paulsen, J
    Wingender, E
    Wray, V
    [J]. BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1996, 377 (03): : 175 - 186
  • [6] BETA-ASPARTYL PEPTIDES IN ENZYMATIC HYDROLYSATES OF PROTEIN
    HALEY, EE
    CORCORAN, BJ
    DORER, FE
    BUCHANAN, DL
    [J]. BIOCHEMISTRY, 1966, 5 (10) : 3229 - &
  • [7] NUCLEOTIDE-SEQUENCE OF CLONED CDNAS ENCODING HUMAN PREPROPARATHYROID HORMONE
    HENDY, GN
    KRONENBERG, HM
    POTTS, JT
    RICH, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (12): : 7365 - 7369
  • [8] Landon, 1977, Methods Enzymol, V47, P145
  • [9] THE ANABOLIC EFFECTS OF HUMAN PARATHYROID-HORMONE (HPTH) ON RAT VERTEBRAL BODY-MASS ARE ALSO REFLECTED IN THE QUALITY OF BONE, ASSESSED BY BIOMECHANICAL TESTING - A COMPARISON STUDY BETWEEN HPTH-(1-34) AND HPTH-(1-84)
    MOSEKILDE, L
    SOGAARD, CH
    DANIELSEN, CC
    TORRING, O
    NILSSON, MHL
    [J]. ENDOCRINOLOGY, 1991, 129 (01) : 421 - 428
  • [10] PEPTIDE-MAPPING OF RECOMBINANT HUMAN PARATHYROID-HORMONE BY ENZYMATIC DIGESTION AND SUBSEQUENT FAST-ATOM-BOMBARDMENT MASS-SPECTROMETRY
    NABUCHI, Y
    KUBONIWA, H
    TAKASU, H
    ASOH, Y
    USHIO, H
    [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 1995, 9 (04) : 257 - 260